Reading biomarkers in a snap

We are building the next generation of rapid diagnostics by using particle assay parallelization powered by imaging and AI to move testing out of the lab and into everyday life.

Request info See how it works

Rapid Diagnostics • At-Home Quantitation • Telemedicine • Remote Patient Monitoring

About

Our company sees tremendous opportunity to develop a new generation of high-sensitivity diagnostics for at-home use by leveraging discoveries in super-resolution imaging, AI, and nanoparticle engineering. Our mission is to enable high-sensitivity diagnostics with low cost components - such as a smartphone camera.

Why now

Sensor tech, mobile compute, and at-home care have converged—enabling diagnostics beyond centralized labs.

What we deliver

Lower cost, faster trial endpoints, and continuous patient monitoring with minimal hardware.

Technology

Talk to an engineer →

Digital Molecular Assays

The vast majority of assays are analog, in which the signal readout is the average of 10s or 1000s of analyte molecules. ilytica has developed a low-cost digital platform – allowing for individual analytes to be resolved while also allowing our AI models to correct some of the false-positive signals before aggregation into a finalized readout.

This dramatically increases sensitivity and more importantly robustness. Importantly, the ilytica platform doesn't count a fixed number of particles, but can increase the counts arbitrarily to attain the desired level of sensitivity for your biomarker of interest.